Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 21 Nov 2023 – 20 Aug 2026, limited by quant Momentum Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant Momentum Fund | Nifty 500 |
|---|---|---|
| 21 Nov 2023 | ₹100.00 | ₹100.00 |
| 13 Feb 2024 | ₹128.40 | ₹112.23 |
| 06 May 2024 | ₹142.87 | ₹118.37 |
| 29 Jul 2024 | ₹162.58 | ₹132.71 |
| 20 Oct 2024 | ₹153.83 | ₹132.98 |
| 12 Jan 2025 | ₹138.82 | ₹123.66 |
| 06 Apr 2025 | ₹133.09 | ₹118.03 |
| 28 Jun 2025 | ₹149.41 | ₹134.00 |
| 20 Sep 2025 | ₹145.65 | ₹133.24 |
| 12 Dec 2025 | ₹147.62 | ₹134.60 |
| 06 Mar 2026 | ₹139.62 | ₹127.53 |
| 28 May 2026 | ₹157.36 | ₹130.29 |
| 20 Aug 2026 | ₹157.48 | ₹133.39 |
| Metric | quant · Direct NAV ₹15.77 Very High risk ★★★☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +9.02% | +7.23% | |
| — | +16.94% | |
| — | +14.70% | |
| — | +15.10% | |
| +17.98% | +14.07% | |
| +7.28% | — | |
| — | +17.59% | |
| — | +16.29% | |
| — | +16.00% | |
| Risk | ||
| 17.32% | 15.69% | |
| 0.15 | 0.52 | |
| 0.20 | 0.73 | |
| -22.67% | -23.08% | |
| Nifty 500 | — | |
| +6.79% | +4.66% | |
| 1.14 | 0.96 | |
| 130.2% | 109.1% | |
| 104.0% | 91.0% | |
| 1.90% | 1.14% | |
| ₹1,323Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 45% | |
| Sanjeev Sharma | — | |
| 21 Nov 2023 | — | |
| 16 | — | |
| 61.7% | — | |
| 3.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.